Alzheimer's disease and cholesterol: the fat connection.
about
The Rationale for Insulin Therapy in Alzheimer's DiseaseImportance of Apolipoprotein A-I in Multiple SclerosisHigher incidence of mild cognitive impairment in familial hypercholesterolemia.The effects of cholesterol on learning and memory.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking Niemann-Pick type C1 proteinGenetics of Alzheimer diseaseLipid raft redox signaling: molecular mechanisms in health and disease.Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD modelNeurometabolic roles of ApoE and Ldl-R in mouse brainMechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts.Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer diseaseClinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbitsAstrocyte-neuron interactions in neurological disorders.Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria.Protective Effect of Genistein against Neuronal Degeneration in ApoE-/- Mice Fed a High-Fat Diet.Membrane rafts in Alzheimer's disease beta-amyloid production.Pore formation in lipid bilayer membranes made of phosphatidylcholine and cholesterol followed by means of constant current.Possible Role of Common Spices as a Preventive and Therapeutic Agent for Alzheimer's DiseaseRosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation.The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis.Progress in the development of new drugs in Alzheimer's disease.Cardiovascular dementia - a different perspective.Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal MembranesTargeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model.Overlooked Alzheimer's smoking gun?Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes.The association of total cholesterol with processing speed is moderated by age in mid- to late-age healthy adults.Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence.α-Tocopherol regulates ectonucleotidase activities in synaptosomes from rats fed a high-fat diet.The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats.
P2860
Q26744834-62173621-173F-48E7-AB96-471B6089E939Q26774792-C583D507-B2E4-4766-99B2-71375FDEDEC5Q33750064-ED9981E3-E79B-43E2-8C1F-0DD8FDEF1F50Q33976829-56575E2D-E24F-4148-90EA-3F58B563C2A2Q34193337-A269630A-7143-49AC-9263-6A4C2928F6FCQ34556705-CAA25D68-5FA1-4CA6-98B1-EE691BA25FCCQ34575511-31492FC5-F103-459A-B3F3-71C7A08D4471Q34604101-45509498-54D1-4387-B7DA-463A2F48433DQ35101890-05AA0BCC-F52A-402B-A422-2DD1EDC03DB1Q36428502-342C0094-8998-439C-B83A-94A9B7218D2FQ36522825-6F5122FF-FBC5-48FC-8182-CBCACFDCAE13Q36870561-99F2D9D0-120E-4DCA-8376-C3F7C0F04A42Q37080888-161557F8-0BDC-427C-8704-5A98838855DCQ37181292-BDCE0DBB-B66A-4943-AF93-19709E4B65AAQ37361072-B6D17931-DFA5-4D57-ABC8-8242ABCF9C19Q37413630-31D668A6-A13B-4A6F-9C65-E65E2DFDCF5AQ37463231-436758BE-E649-40B2-94CF-8A9E3C628422Q37715176-68B6A59C-3AEF-4B82-BA43-983A52DB64E5Q38429631-E5B13963-70C9-4BE7-B289-F06ADB84B11FQ38751711-821F8F62-E3AE-4948-9FE8-CE522AD209FDQ38820490-BA78C3AF-BA58-4CF0-A2A7-DC65BE8C81B2Q39003622-8FA88E50-D23F-4118-A89C-8DA8C305A658Q39789745-F705438C-BB5C-497B-BFA5-32B205C6817EQ40361355-43352AB0-D5A2-44E3-A9D1-31BE1DD5582BQ41604924-E151C4D5-435D-4D7A-B3B0-7B7CA4FFBD80Q43151578-D86D473B-9CCA-4805-A0B7-0D8A767A9447Q44024738-7E3B4BFB-FFC9-4169-A6DB-2ECCA8B7121BQ44091518-05A6698D-5BB6-4533-9D5B-104A2B0ECDBDQ47558648-B39DE8AF-E337-4D23-B945-FAE08C1B3636Q48274225-563EFEA1-D61D-43CE-8B28-F7E15EC5444FQ48725215-C3F2A80C-3CDA-4BFC-9712-278125962A19Q49065735-E88B39B1-E84A-4E80-8E20-A484A92D80EF
P2860
Alzheimer's disease and cholesterol: the fat connection.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Alzheimer's disease and cholesterol: the fat connection.
@ast
Alzheimer's disease and cholesterol: the fat connection.
@en
type
label
Alzheimer's disease and cholesterol: the fat connection.
@ast
Alzheimer's disease and cholesterol: the fat connection.
@en
prefLabel
Alzheimer's disease and cholesterol: the fat connection.
@ast
Alzheimer's disease and cholesterol: the fat connection.
@en
P2860
P1476
Alzheimer's disease and cholesterol: the fat connection.
@en
P2093
John B Clark
Laura Canevari
P2860
P2888
P304
P356
10.1007/S11064-006-9200-1
P577
2006-12-27T00:00:00Z